NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

Tower's risk-based revolution
Markets

Tower's risk-based revolution

It's one of the few insurers in Australasia growing. How?

RBNZ plan to cut AT1 capital layer wins cautious lender support
Finance

RBNZ plan to cut AT1 capital layer wins cautious lender support

Proposal to pare AT1 capital from prudential stacks wins cautious support from lenders.

NZ sharemarket starts week down 0.8%
Markets Market Close

NZ sharemarket starts week down 0.8%

The S&P/NZX 50 Index closed at 13,351.92, down 115.34 points or 0.86%.

Graham Skellern 13 Oct 2025
ANZ NZ continues to hold market-leading position: ANZ Group
Finance

ANZ NZ continues to hold market-leading position: ANZ Group

ANZ NZ holds market-leading position, continues re-platforming: ANZ Group 

Staff reporters 13 Oct 2025